Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Bayer describes new oxazolidinone antibacterials in recently issued patent

Feb. 2, 1999

Regulatory plans for gatifloxacin outlined by Kyorin

Feb. 1, 1999

Daiichi patents broad-spectrum antibacterial series

Feb. 1, 1999

Canadian company formed to develop nucleic acid-based antiinfective drugs

Jan. 29, 1999

FDA advisory committee scheduled to discuss Relenza NDA

Jan. 29, 1999

Broad-spectrum antibacterial agents discovered at Daiichi

Jan. 29, 1999

Small Molecule Therapeutics identifies antibacterial class of compounds

Jan. 28, 1999

Phase II study initiated by Neose for otitis media prevention

Jan. 28, 1999

Topical magainin antibiotic for diabetic foot ulcers scheduled for FDA advisory committee review

Jan. 27, 1999

Public and private sectors team up to develop new antimalarial drugs

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.